https://www.selleckchem.com/pr....oducts/zongertinib.h
3. In 3 treatments, hemorrhage was diagnosed on or after 8 days of RFA, all of which were in the antithrombotic group. Thrombotic complications were diagnosed after 2 treatments (0.2%) in the antithrombotic group and after 5 (0.1%) in the control group. In a multivariate analysis, receiving antithrombotic therapy was not an independent risk factor for hemorrhagic complications (adjusted odds ratio, 1.52; 95% confidence interval, 0.60-3.87; P= .38). RFA of liver tumors in patients on antithrombotic therapy is generally safe with ap
Gefällt mir
Kommentar
Teilen
